Stock Market & Financial Investment News

News Breaks January 3, 2013 19:33 EDT GEVA Synageva Biopharma 2.15M share Secondary priced at $47.53 Morgan Stanley and JPMorgan acted as joint book running managers for the offering. News For GEVA From The Last 14 Days Check below for free stories on GEVA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for GEVA Sign up for a free trial to see the rest of the stories you've been missing.